Page last updated: 2024-10-31

midazolam and Bronchial Hyperreactivity

midazolam has been researched along with Bronchial Hyperreactivity in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Bronchial Hyperreactivity: Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borgeat, A1
Wilder-Smith, O1
Suter, PM1

Other Studies

1 other study available for midazolam and Bronchial Hyperreactivity

ArticleYear
The effect of sedation with propofol on postoperative bronchoconstriction in patients with hyperactive airway disease.
    Intensive care medicine, 1992, Volume: 18, Issue:8

    Topics: Bronchial Hyperreactivity; Drug Therapy, Combination; Humans; Midazolam; Postoperative Complications

1992